» Articles » PMID: 34308533

Dementia Risk in the General Population: Large-scale External Validation of Prediction Models in the AGES-Reykjavik Study

Overview
Journal Eur J Epidemiol
Specialty Public Health
Date 2021 Jul 26
PMID 34308533
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

We aimed to evaluate the external performance of prediction models for all-cause dementia or AD in the general population, which can aid selection of high-risk individuals for clinical trials and prevention. We identified 17 out of 36 eligible published prognostic models for external validation in the population-based AGES-Reykjavik Study. Predictive performance was assessed with c statistics and calibration plots. All five models with a c statistic > .75 (.76-.81) contained cognitive testing as a predictor, while all models with lower c statistics (.67-.75) did not. Calibration ranged from good to poor across all models, including systematic risk overestimation or overestimation for particularly the highest risk group. Models that overestimate risk may be acceptable for exclusion purposes, but lack the ability to accurately identify individuals at higher dementia risk. Both updating existing models or developing new models aimed at identifying high-risk individuals, as well as more external validation studies of dementia prediction models are warranted.

Citing Articles

Predicting incident dementia in community-dwelling older adults using primary and secondary care data from electronic health records.

Georgiev K, Wang Y, Conkie A, Sinclair A, Christodoulou V, Seyedzadeh S Brain Commun. 2025; 7(1):fcae469.

PMID: 39759471 PMC: 11697165. DOI: 10.1093/braincomms/fcae469.


Identifying individuals at high risk for dementia in primary care: Development and validation of the DemRisk risk prediction model using routinely collected patient data.

Reeves D, Morgan C, Stamate D, Ford E, Ashcroft D, Kontopantelis E PLoS One. 2024; 19(10):e0310712.

PMID: 39365767 PMC: 11452046. DOI: 10.1371/journal.pone.0310712.


Latent profiles of modifiable dementia risk factors in later midlife: relationships with incident dementia, cognition, and neuroimaging outcomes.

Xiong L, Wood Alexander M, Wong Y, Wu C, Ruthirakuhan M, Edwards J Mol Psychiatry. 2024; 30(2):450-460.

PMID: 39103532 DOI: 10.1038/s41380-024-02685-4.


How many future dementia cases would be missed by a high-risk screening program? A retrospective cohort study in a population-based cohort.

Walsh S, Wallace L, Merrick R, Hayat S, Luben R, Mytton O Alzheimers Dement. 2024; 20(9):6278-6286.

PMID: 39023302 PMC: 11497639. DOI: 10.1002/alz.14113.


What's New in Dementia Risk Prediction Modelling? An Updated Systematic Review.

Brain J, Kafadar A, Errington L, Kirkley R, Tang E, Akyea R Dement Geriatr Cogn Dis Extra. 2024; 14(1):49-74.

PMID: 39015518 PMC: 11250535. DOI: 10.1159/000539744.


References
1.
Vonk J, Arce Renteria M, Medina V, Pericak-Vance M, Byrd G, Haines J . Education Moderates the Relation Between APOE ɛ4 and Memory in Nondemented Non-Hispanic Black Older Adults. J Alzheimers Dis. 2019; 72(2):495-506. PMC: 8876947. DOI: 10.3233/JAD-190415. View

2.
Barnes D, Beiser A, Lee A, Langa K, Koyama A, Preis S . Development and validation of a brief dementia screening indicator for primary care. Alzheimers Dement. 2014; 10(6):656-665.e1. PMC: 4119094. DOI: 10.1016/j.jalz.2013.11.006. View

3.
Sachdev P, Lipnicki D, Crawford J, Reppermund S, Kochan N, Trollor J . Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study. PLoS One. 2013; 8(3):e59649. PMC: 3609866. DOI: 10.1371/journal.pone.0059649. View

4.
Albert M, DeKosky S, Dickson D, Dubois B, Feldman H, Fox N . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):270-9. PMC: 3312027. DOI: 10.1016/j.jalz.2011.03.008. View

5.
Collins G, Reitsma J, Altman D, Moons K . Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. BMC Med. 2015; 13:1. PMC: 4284921. DOI: 10.1186/s12916-014-0241-z. View